Stockreport

McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug [Yahoo! Finance]

McKesson Corporation  (MCK) 
Last mckesson corporation earnings: 2/4 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.mckesson.com
PDF selected by Accord BioPharma, Inc. as an exclusive specialty pharmacy provider for CAMCEVI (leuprolide) 42mg injection emulsion for subcutaneous use. CAMCEVI is a gonado [Read more]